The neurophysiological underpinnings involved in susceptibility to and maintenance of anxiety 39 are not entirely known. However, two stress-responsive systems, the hypothalamic-pituitary-40 adrenal axis and the endocannabinoid system, may interact in anxiety. Here, we examine the 41 relationship between FAAH genotype, CRFR1 genotype, baseline cortisol, and state anxiety in a 42 rural adult population using data from Project FRONTIER. We predicted that FAAH A (AA and 43 AC vs CC; rs324420) and three CRFR1 SNP minor alleles (rs7209436 C T [minor allele]; 44 rs110402, G A [minor]; and rs242924 G T [minor]), would interact to predict low baseline 45 cortisol and low state anxiety scores. We found partial support for our prediction. In CRFR1 46 minor carriers, the FAAH AA or AC (vs. CC) genotype was associated with higher cortisol and 47 with lower anxiety. In CRFR1 non-minors, those with FAAH AA or AC (vs. CC) showed 48 decreased cortisol and higher anxiety. These results suggest that FAAH CC genotype only 49 conveys risk for anxiety in individuals who are also carriers of the CRFR1 minor combination. 50 FAAH genotype was significantly associated with baseline cortisol but was not independently 51 associated with anxiety. Contrary to our predictions, baseline cortisol was negatively associated 52 with anxiety. Lastly, we did not find any independent relationships between any of our SNPs and 53 baseline cortisol or anxiety. These data suggest FAAH and cortisol interact to predict state 54 anxiety, but that the relationship depends on CRFR1 genotype. The Project FRONTIER dataset 55 is supported by Texas Tech University Health Sciences Center Garrison Institute on Aging. 56 57 58 59 60 61
According to National Institute of Mental Health (NIMH), over 40 million adults in the US, or 64 roughly 18% of the population, suffer from anxiety, and nearly 30% of adults will experience an 65 anxiety disorder during their lifetime (NIMH; Anxiety and Depression Association of America). 66
Despite its prevalence, the neurobiological underpinnings of anxiety onset and maintenance are 67 not fully understood. Using the NIMH Research Domain Criteria (RDoC) approach (Cuthbert & 68 Insel, 2013) , recent studies using humans and animal models have determined various 69 biomarkers specific to anxiety. The RDoC aims to incorporate many dimensions including 70 behavior, genetics, neurobiology, environment, and experiential effects into diagnosis and 71 categorization of mental disorders, with the goal that doing so will aid in understanding disease 72 etiology and will enhance treatment options (Insel, 2014 ) also see [Holmes & Patrick, 2018] ). 73
Due to the reliance on fear and threat in the diagnosis of anxiety disorders, studies have 74 focused on the physiological systems associated with response to threats (stressors), 75 specifically the hypothalamic-pituitary-adrenal (HPA) axis and the endocannabinoid system 76 Additionally, anxiety is thought to be at least partially mediated by corticotropin-releasing 90 factor (CRF) binding to CRFR1 in the limbic system, mainly the amygdala ( Zorrilla et al., 2002) . CRF primarily binds to one of two 93 receptors, CRFR1 or CRFR2, but has higher affinity for CRFR1 and this receptor predominates 94 in the hypothalamus, amygdala, cerebellum, pituitary and cerebral cortex (Sanders & Nemeroff, 95 2016 ). Hypothalamic CRF is important for initiation of the hypothalamic-pituitary-adrenal (HPA) 96 axis, whereas CRF in the limbic system is important for the autonomic (sympathetic nervous 97 system) and behavioral responses to stress, and is involved in fear and anxiety (Arborelius et 98 al., 1999; Heinrichs & Koob, 2004; McEwen et al., 2015; Müller et al., 2003; Perusini & 99 Fanselow, 2015) . Hypothalamic and limbic CRF are independently regulated, but HPA axis 100 output can potentiate the effect of limbic CRF as glucocorticoid binding in the amygdala 101 increases CRF concentrations in that area (Binder & Nemeroff, 2010; Rosen & Schulkin, 1998) , 102 providing a possible link between elevated circulating glucocorticoids, CRF, and anxiety. 103
Although various manipulation studies in rodents (e.g., knockout of CRFR1, injection of 104 CRF, injection of CRF antagonists) have shown that increased limbic CRF is anxiogenic, and 105 that this response is driven by binding to CRFR1, the correlational data from humans is mixed 106 (Arborelius et al., 1999; Sanders & Nemeroff, 2016) . But, recent evidence suggests that CRF-107 related single nucleotide polymorphisms (SNPs) might be partially responsible for these 108 discrepancies in the human literature and may help to explain risk and resilience (Binder & The endocannabinoid (eCB) system is a neuromodulatory network involved in the regulation 118 of several stress-responsive neural circuits and can impact HPA axis activity (Gorzalka et al., 119 2008; Hill & McEwen, 2010; Hill & Tasker, 2012; McEwen et al., 2015) . The two major signaling 120 molecules of the eCB system are N-arachidonoylethanolamine (anandamide; AEA) and 2-121 arachidonoylglycerol (2-AG), which are synthesized post-synaptically (Hillard et al., 2011) . 122
Endocannabinoids bind to CB1 and CB2 receptors. CB1 receptors are the most abundant G-123 protein-coupled receptors in the central nervous system and are found on GABAergic, 124 glutamatergic, serotonergic, noradrenergic, and dopaminergic terminals, but the predominant 125 effects of eCB signaling result from modifying GABA and glutamate release (see Morena et al., 126 2016) . Regulation of eCBs is done primarily via degrading enzymes, namely fatty acid amide 127 hydrolase (FAAH) which metabolizes AEA, and monoacylglyceride (MAG) lipase, which 128 metabolizes 2-AG. Genetic variability in the gene encoding FAAH may impact anxiety. 129
When taken together, data suggest CRF plays a central role in linking the HPA axis, the 140 eCB system, and the amygdala with anxiety (Hill et al., 2009; 2010a; Hillard et al., 2011) . In 141 elaborate studies in mice, Gray and colleagues showed stress-associated 142 increase in CRF concentration in the amygdala resulted in CRFR1 activation, an increase in 143 FAAH activity, and thus decrease AEA levels. Overall, this cascade results in decreased AEA 144 binding to CB1 receptors resulting in increased glutamate release, and increased activity of the 145 basolateral amygdala resulting in increased expression of anxiety-like behaviors (Gray et al., 146 2015) ; this effect appeared to be independent of initial stress-related glucocorticoid increase. 147
These data suggest one mechanism by which stress increases anxiety is via CRFR1 impacts on 148 FAAH activity and AEA binding in the basolateral amygdala. Another recent study using a FAAH 149 inhibitor in rats corroborates these findings (Natividad et al., 2017) . 150
Given the relationships among the HPA axis, CRFR1, FAAH, and anxiety, we hypothesized 151 that baseline cortisol and SNPs in CRFR1 and FAAH genes interact to influence state anxiety in 152 humans (see Figure 1 ). Here, we determined if baseline cortisol, FAAH, and CRFR1 SNPs are 153 related to state anxiety levels, measured via the Beck Anxiety Inventory (BAI), in an aged, 154 majority Hispanic, rural, community dwelling human population. We proposed a moderated 155 mediation in that baseline cortisol mediates the relationship between FAAH SNP (rs324420) 156 and state anxiety, and that effect is moderated by CRFR1 genotype. Specifically, we predict that 157 FAAH A (AA and AC vs CC) and CRFR1 SNP minor alleles (AA, TT, TT) will interact to predict 158 low baseline cortisol and those individuals will have the lowest state anxiety scores. by Project FRONTIER coordinators. Authors of this study did not directly interact with any of the 185 participants. Authors obtained the following de-identified samples or variable data for 193 186 individuals: frozen whole blood, frozen serum, Beck Anxiety Inventory scores, last grade level 187 completed in school, sex, age, race (white/Caucasian, black, or other), and ethnicity (Hispanic 188 or not Hispanic). Participants from this study were community dwelling at the time of data 189 collection and as long as they were over 40, were not excluded from the study for any reason.
The average age of entry into the study was 58.27 yrs (range 40-87). Data obtained for this 191 study were from the second appointment (year 3 of study). 192
Demographic information for the 193 participants is as follows: 92.2% Caucasian, 50.5% 193
Hispanic, and 72.5% female. Self-reported highest grade level completed averaged 10.1 (range: 194 0-19). The average age at interview and data collection for samples obtained for our analysis 195 was 61.09 yrs (std dev. 11.66, range: 42-90). All procedures performed by the authors were 196 approved by the Texas Tech University IRB. 197 198
Project FRONTIER Beck Anxiety Inventory (BAI) 199
The BAI is a commonly used 21-item, self-report questionnaire which asks participants to 200 rank anxiety symptoms on their severity over the past week using a 0-3 point Likert scale (Beck 201 et al.,1988; Beck & Steer, 1990) . The test has high internal reliability and discriminant validity 202 from blood and frozen in aliquots in the biobank. All blood samples were collected between 7:30 232 AM and 2:45 PM (only two samples were collected after 12 noon), and 90% of samples were 233 collected between 7:00 and 9:30 AM, thus we used time of day as a covariate in analyses. minor grouping, the total n is 185 as we were able to include all participants with known CRFR1 248 genotype because even if they were missing data for one SNP, the other two did not meet the 249 CRFR1 minor criteria. is associated with increased cortisol and here increased cortisol is associated with lowered 269 anxiety. Overall, the moderated mediation results suggest that the mediation of cortisol between 270 FAAH_A and anxiety goes in one direction for CRF1_minor carriers and goes in the opposite 271 direction for CRF1_non-minors. A summary of predictions and results are presented in Table 1  272 and results from the model are presented in Figure 2 . 273 274
Genotypes and associations between SNPs, cortisol, and anxiety 275
Genotype data are shown in Table 2 . Individual genotype did not impact baseline cortisol 276 (Table 3) or scores on the Beck Anxiety Inventory (Table 4 ). Baseline cortisol and state anxiety 277 were negatively correlated in our total sample: as cortisol decreased, anxiety increased (r = -278 0.175, p = 0.015, n = 191). 279 280
DISCUSSION 281
We found partial support for our prediction that FAAH A (AA and AC vs CC) and CRFR1 282 SNP minor alleles (AA, TT, TT), would interact to predict low baseline cortisol and low state 283 anxiety scores. In CRFR1 minor carriers, the FAAH AA or AC (vs. CC) genotype was 284 associated with higher cortisol and with lower anxiety. Additionally, in CRFR1 non-minors, those 285 with FAAH AA or AC (vs. CC) showed decreased cortisol and higher anxiety. Based on data 286 from this population, it seems the minor alleles of CRFR1 and the AA or AC genotype of FAAH 287 are related to reduced anxiety, but, surprisingly, related to higher, and not lower, baseline 288 cortisol. Additionally, among individuals with the protective CRFR1 minor combination, those 289 with the FAAH CC genotype that confers risk had higher anxiety, but, those with the FAAH CC 290 genotype and without the protective CRFR1 minor combination had lower anxiety. Thus, it 291 seems the FAAH CC genotype only confers risk for anxiety in individuals who are also carriers 292 of the CRFR1 minor combination. When dissecting our model overall, FAAH genotype was 293 significantly associated with baseline cortisol, in that CC individuals had higher cortisol than did 294 M A N U S C R I P T
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AA and AC individuals, which is in line with our initial predictions. But, FAAH genotype was not 295 independently associated with anxiety, and baseline cortisol was negatively associated with 296 anxiety score; as cortisol decreased, anxiety increased, which is contrary to our prediction. 297
Lastly, contrary to other studies we did not find any independent relationships between any 298 SNPs and baseline cortisol or anxiety score. 299
Although unexpected based on our predictions, low baseline and post-stress cortisol being 300 associated with high anxiety has been previously documented in both clinical and healthy interactions of these systems as more work has investigated impacts of acute or chronic stress 338 and/or artificial glucocorticoid elevation, and, due to ability to control variables and manipulate 339 and analyze brains, rodents have been the primary study species. Future studies to illuminate 340 more precisely how durations (acute vs. chronic) and species-specific levels (e.g., circadian 341 peak or post-stress) of glucocorticoid increase alter amygdalar AEA and FAAH, and anxiety-like 342 behavior are needed to determine the interacting role these systems play in anxiety. For our 343 study, it is important to point out that no specific stressor was applied prior to collection of blood 344 samples used for assay of cortisol, but it is possible that hormone levels were not true are lower in those with increased anxiety. Additionally, we were not able to measure AEA in our 350 study, but future studies should measure levels of circulating glucocorticoids and 351 endocannabinoids in the same participants. 352
We found the FAAH CC genotype is only confers risk for anxiety if the CRFR1 minor allele 353 combination is also present. Additionally, the FAAH AA/AC genotype was riskier than the CC if 354 the three CRFR1 minor alleles were not present. This result is somewhat contrary to our 355 prediction as we hypothesized the FAAH AA/AC and the CRFR1 minor combination would 356 buffer individuals from anxiety both in combination and on their own. While it is unknown why 357 we found this flipped effect of FAAH SNP depending on CRFR1 SNP status, it may be that in 358 response to CRF signaling (which may vary by genotype and/or stress), individuals with higher 359 baseline AEA (those with AA/AC) experience a greater relative drop in AEA compared to the CC 360 individuals that started with less AEA. If the greater drop corresponds to proportionally greater 361 release of inhibition (by decreased binding at more CB1 receptors) it may therefore relate to 362 more glutamatergic output and thus higher BLA activity and increased anxiety. To our 363 knowledge, information on the specific AEA binding dynamics and numbers of CB1 receptors in 364 the BLA among individuals who differ in FAAH genotype is not available. However, data from 365 rodents suggest that the level of CB1 binding is important for signaling -the higher the CB1 366 agonist concentration, the lower the firing rate of BLA neurons (Pistis et al., 2004 ), suggesting 367 that a more pronounced decrease in AEA could possible result in greater BLA output. 368
Additionally, recent work highlights the importance of CB1 in understanding the interactions 369 among the EC system, stress, and anxiety. For example, chronic stress, sustained 370 glucocorticoids, and early life stress can decrease CB1 receptor density in the brain; blocking 371 CB1 can increase anxiety in baseline and post-stress scenarios and can increase HPA axis Moreover, another recent study found FAAH A carriers had higher anxiety (and depression) 374 than CC individuals, but only if they were exposed to childhood adversity (Lazary et al., 2016) ; 375 CRFR1 genotype, CB1, and cortisol were not assessed. These data suggest that the role of 376 CB1 is likely important and may help to explain how gene by environment interactions impact 377 anxiety. Future studies should determine if CRFR1 minor alleles play a role in the relationship 378 between FAAH genotype, CB1 dynamics, and anxiety. 379
It is important to note that despite the abundance of data on the role of CRFR1 SNPS in 380 various stress and affective state outcomes, it is unclear what the functional significance of 381 these SNPS are at the molecular/cellular level (Binder and Nemeroff, 2010) . The gene encoding 382 homozygous for the common allele of rs7209436 (CC) and rs110402 (GG); authors did not 400 report main effects of genotype on anxiety measures (Mahon et al., 2013) . Thus, it is therefore 401 possible that a gene by environment interaction is important for interpreting the role of CRFR1 402 and FAAH genotype (see Lazary et al., 2016) in stress physiology and affect (Heim and Binder, 403 2012) . In line with this, recent studies have shown that early life trauma can lead to differential 404 DNA methylation (Roberts et al., 2018) and that this impact is directly related to stress-405 responsive genes (FKBP5) and affect, mainly depression (Binder, 2009; Binder et al., 2008; A. 406 Zannas & Binder, 2014; Zannas et al., 2016) . We do not have information on exposure to early 407 life trauma in our study population, but this would be an interesting area for future study. 408
Overall, we partially confirmed our predictions, and, when compared to the other existing 409 dataset exploring the interaction among CRFR1, FAAH, and anxiety, our data are somewhat 410 confirmatory. Demers and colleagues (Demers et al., 2016) found one (protective) CRFR1 411 minor allele (rs110402) and the (less risky) FAAH AA or AC alleles were associated with 412 increased anxiety disorder diagnosis; they did not measure baseline cortisol. However, if the 413 individuals in the Demers study were non-minor at CRFR1 rs7209436 and rs242924, then their 414 participants would match our results of FAAH AA or AC being riskier for anxiety in individuals 415 who were not carriers of all three minor alleles. But, the sample populations in the two studies 416 were not identical. In our sample, it is important to note that individuals were not clinically 417 anxious, and our anxiety scores represent natural variation in state (current) anxiety in a 418 population; whereas the individuals in the Demers et al study met DSM-5 criteria for anxiety 419 disorder. However, data suggest that state, trait, and clinical anxiety are related and therefore 420 biomarkers related to one of these measures may be relevant for all of them. For example, state 421 anxiety increases after stress (Ackerl et al., 2002) and this is true for individuals high and low for 422 anxiety are highly correlated (Spielberger et al.,1983) and individuals with higher levels of 426 anxiety sensitivity are more at-risk for clinical anxiety disorders (Naragon-Gainey, 2010). 427
Nonetheless, it is possible that biomarkers of state anxiety and those for trait or pathological 428 anxiety differ. 429
In conclusion, in our study population, the minor alleles of CRFR1 and the AA or AC 430 genotype of FAAH are related to reduced anxiety, but, surprisingly, related to higher, and not 431 lower, baseline cortisol. Additionally, the FAAH CC genotype is only confers risk for anxiety in 432 individuals who are also carriers of the CRFR1 minor combination. But, FAAH genotype was not 433 independently associated with anxiety, and baseline cortisol was negatively associated with 434 anxiety score. These results may help to interpret how genetic differences in the HPA axis and Institute on Aging for their support. We extend a special thank you to Dr. Linda Yin for her 446 support and wisdom, and for her exceptional work on, and dedication to, the Project FRONTIER 447 biobank. Lastly, we would like to thank two anonymous reviewers for their helpful comments Table 1 . Summary of predictions and results. Results that correspond with predictions are shown in bold, results that did not are italicized. We predicted that FAAH A (AA and AC vs CC) and CRFR1 SNP minor alleles (AA, TT, TT) would interact to predict low baseline cortisol and the lowest state anxiety scores. We predicted the CC FAAH genotype (increased FAAH activity) would have high baseline cortisol and high anxiety scores. Additionally, we predicted CRFR1 minor allele carriers would show low cortisol and low anxiety. 
